Six in ten American adults have at least one chronic condition. Four in ten have two or more. Heart disease, diabetes, obesity, cancer, autoimmune disorders, dementia, and depression have become so prevalent that the medical establishment has largely normalized them — treating them as inevitable features of aging rather than as what the evidence increasingly shows them to be: the predictable consequences of a food system, a farming system, an environmental policy framework, and a healthcare financing architecture that have all, in different ways, failed the same people at the same time.

The direct annual economic cost of chronic disease in the United States now exceeds $4.1 trillion. More than ninety cents of every healthcare dollar is spent on treating conditions that in many cases could have been prevented or reversed upstream. The United States spends more on healthcare than any other wealthy nation and produces worse population health outcomes across nearly every major chronic disease category. Children are sicker than their parents were at the same age. Life expectancy, after decades of gradual improvement, has been declining.

The MAHA movement's foundational insight is that this is not an accident. The chronic disease epidemic has been shaped — and its solutions blocked — by a set of mutually reinforcing industry interests that have dominated American food, farming, pharmaceutical, and healthcare policy for decades.

The food industry optimized for shelf life, palatability, and profit margins rather than nutritional value. Ultra-processed foods now represent more than sixty percent of the American caloric supply. They are engineered to override satiety signals, drive overconsumption, and produce the metabolic dysfunction that fills the offices of every endocrinologist and cardiologist in the country.

The pharmaceutical industry captured the research agenda. NIH funding flows toward patentable interventions rather than lifestyle and nutritional medicine. Medical education devotes an average of fewer than twenty hours to nutrition across four years of training. Insurance reimbursement structures reward procedures over prevention, volume over outcomes, and late-stage treatment over the upstream work that would have made it unnecessary.

The public understands this with unusual clarity. Ninety percent of Americans are concerned about pharmaceutical industry influence on public policy — the highest score of any issue tested in recent national polling. Eighty-six percent support combating corporate capture in medicine.

Of all the dimensions of this failure, the lockout of integrative and preventive medicine is among the most specific, most documented, and most long-standing. The practitioners who work in this space — naturopaths, acupuncturists, osteopaths, functional medicine doctors, health coaches, nutritionists, environmental medicine specialists — have been fighting for professional and financial recognition for four decades.

The fight is not primarily about clinical evidence, though the evidence base for many integrative approaches is substantial and growing. It is about billing architecture. The CPT-code universe that governs insurance reimbursement was designed in the 1960s and 1970s around fee-for-service hospital and physician care. It has never been fundamentally revised, because the institutions that benefit from it — insurers, hospital systems, pharmaceutical manufacturers, and organized medicine — have consistently had more lobbying power than the practitioners and patients who would benefit from revision.

The result is perverse. A patient who sees a functional medicine physician to address the metabolic root causes of their Type 2 diabetes may achieve better outcomes than one who sees a conventional endocrinologist and receives a prescription for Metformin. But the functional medicine visit is likely not covered by insurance. The Metformin is. The incentive structure of the entire healthcare financing system points toward the drug and away from the dietary and lifestyle intervention. This is not a scientific judgment. It is a billing-architecture artifact — and it has been producing the same distorted outcomes for fifty years.

For patients, the consequence is a two-tier system in which prevention and integrative care is available on a cash basis to those who can afford it, while the majority are funneled into the conventional system regardless of its suitability for their condition.